Enovis Corporation
ENOV
NYSE·Healthcare·Medical - Devices·Mkt cap $1.1B
$18.56
▼ -4.33%
P/E
—
Mkt Cap
$1.1B
52-Wk Range
$18.52–$34.28
52-Week Range
$18.52 - $34.28
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 40.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Established DJO brand with strong recognition among healthcare professionals
- Comprehensive product portfolio addressing multiple musculoskeletal conditions
- Diversified distribution network spanning direct, retail, and professional channels
- Integrated manufacturing and supply chain capabilities
- Long-standing relationships with orthopedic specialists and healthcare systems
Bear Case
1 risk
- Average volatility.
Growth
Turning profitable
Rising prevalence of musculoskeletal disorders due to aging populations
Value
Deep value opportunity - significant discount to Industrial Machinery peers
Momentum
Falling
-21.6% over 3m
Quality
Strong
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying ENOV right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of $0.90 vs $0.85 consensus (+6.3% surprise). Revenue of $582.8M vs $581.8M expected (+0.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+6.3%
Revenue trend · last 8Q
—
+23%
+8%
+7%
+9%
+3%
+5%
+3%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$505.2M
$561.0M
$558.8M
$564.5M
$548.9M
$575.8M
$589.2M
$582.8M
Margins · last 8Q
Gross
61.6%
Operating
3.0%
Profit
-0.2%
Wall Street consensus
5 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Citi · Sep 2, 2026
vs Industry
How ENOV stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related